Skip to Main Content

Paper Details

Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine.
Mult Scler J Exp Transl Clin
4
2023
Author NameAffiliation
Clare Baecher-AllanBrigham and Women's Hospital
Clare Baecher-AllanHarvard Medical School
Kristin M GalettaBrigham and Women's Hospital
Kristin M GalettaHarvard Medical School
Howard L WeinerBrigham and Women's Hospital
Howard L WeinerHarvard Medical School
  • 1 - 6

Datasets

Release 1.2